Penn Medicine Provider
Transplant Surgery
Matthew H. Levine, MD, PhD
4.9
(42)
Accepting new patients
Sees patients age 18 and up
Penn Transplant Institute - Kidney and Pancreas Transplant
View 2 additional locations

About me

  • Associate Professor of Surgery

Education and training

  • Medical School: Yale University
  • Residency: Massachusetts General Hospital
  • Fellowship: UCSF Medical Center and Hospital

What my patients think about me

Average Rating
4.9

42 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

March 2025
5.0
5.0
none needed, outstanding dr
December 2024
5.0
5.0
competent professional clinician
November 2024
5.0
5.0
confidence
August 2024
5.0
5.0
dr. levine is amazing!

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Levine is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Christensen, L, Levine M Potential nuances in renoprotective properties of estrogen in females , Kidney International: 2024 (accepted for publication)


Cywes C, Banker A, Muñoz N, Levine M, Abu-Gazala S, Bittermann T, Abt P The potential utilization of machine perfusion to increase transplantation of macrosteatotic livers , Transplantation, 108(11): 2024,e370-e375


Concors SJ, Hernandez PT, O’Brien C, DePaolo J, Murken DR, Aufhauser DD, Wang Z, Xiong Y, Krumeich L, Ge G, Beier UH, Bhatti TR, Kozikowski AP, Avelar L, Kurz T, Hancock WW, Levine MH Differential effects of HDAC6 inhibition versus knockout during hepatic ischemia reperfusion injury and the HDAC6 C-terminal zinc-finger ubiquitin-binding domain , Transplantation, 108(10): 2024,2084-2092


Huang KB, Wang FY, Lu Y, Yang LM, Long N, Wang SS, Xie Z, Levine M, Zou T, Sessler JL, Liang H Cu(II) complex that synergistically potentiates cytotoxicity and an antitumor immune response by targeting cellular redox homeostasis , Proceedings of the National Academy of Sciences of the United States of America, 121(24): 2024,e2404668121


Benson AB, D'Angelica MI, Abrams T, Abbott DE, Ahmed A, Anaya DA, Anders R, Are C, Bachini M, Binder D, Borad M, Bowlus C, Brown D, Burgoyne A, Castellanos J, Chahal P, Cloyd J, Covey AM, Glazer ES, Hawkins WG, Iyer R, Jacob R, Jennings L, Kelley RK, Kim R, Levine M, Palta M, Park JO, Raman S, Reddy S, Ronnekleiv-Kelly S, Sahai V, Singh G, Stein S, Turk A, Vauthey JN, Venook AP, Yopp A, McMillian N, Schonfeld R, Hochstetler C NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023 , Journal of the National Comprehensive Cancer Network, 21(7): 2023,694-704


Tran BV, Moris D, Markovic D, Zaribafzadeh H, Henao R, Lai Q, Florman SS, Tabrizian P, Haydel B, Ruiz RM, Klintmalm GB, Lee DD, Taner CB, Hoteit M, Levine MH, Cillo U, Vitale A, Verna EC, Halazun KJ, Tevar AD, Humar A, Chapman WC, Vachharajani N, Aucejo F, Lerut J, Ciccarelli O, Nguyen MH, Melcher ML, Viveiros A, Schaefer B, Hoppe-Lotichius M, Mittler J, Nydam TL, Markmann JF, Rossi M, Mobley C, Ghobrial M, Langnas AN, Carney CA, Berumen J, Schnickel GT, Sudan DL, Hong JC, Rana A, Jones CM, Fishbein TM, Busuttil RW, Barbas AS, Agopian VG Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant Consortium , Liver Transplantation, 29(7): 2023,683-697


Potluri V, Naqvi F, Goldberg DS, Shah M, Loupy A, Abt P, Blumberg E, Trofe-Clark J, Bloom R, Sawinski D, Chattergoon M, Segev DL, Bair-Marcantoni N, Durand CM, Reddy R, Levine M, Brown N, Mapchan S, Aubert O, Desai N, Reese PP Longer-term clinical outcomes from the THINKER and EXPANDER trials of transplantation of HCV-RNA+ donor kidneys into hepatitis C virus-negative recipients , Kidney International Reports, 8(7): 2023,1460-1463


Roll GR, Bray RA, Cooper M, Eagar TN, Gebel HM, Vranic GM, Hitchman KMK, Houp J, Kamoun M, Killian J, Kim J, Kumar V, Levine M, Lovasik BP, Lunow-Luke T, Parsons RF, Pattanayak V, Ranch D, Shah A, Stock PG, Timofeeva OA, Trofe-Clark J, Wongjirad C, Yeh H, Yi S, Rajalingam R COVID-19 infection and vaccination rarely impact HLA antibody profile in waitlisted renal transplant candidates- a multicenter cohort , Human Immunology, 84(4): 2023,278-285


Sonnenberg EM, Hsu JY, Cohen JB, Potluri VS, Geng Z, Levine MH, Abt PL, Reese PP Acute kidney injury in deceased organ donors and kidney transplant outcomes: A national cohort study using a novel data source , Annals of Surgery, 276(6): 2022,e982-e990


Hernandez P, O'Brien C, Concors SJ, Wang Z, Ge G, Hancock WW, Levine MH The selective estrogen receptor modulator, raloxifene, is protective against renal ischemia-reperfusion injury , Transplantation, 106(11): 2022,2166-2171